Cargando…
UK guidelines for the management of bone sarcomas
This document is an update of the British Sarcoma Group guidelines published in 2010. The aim is to provide a reference standard for the clinical care of patients in the UK with bone sarcomas. Recent recommendations by the European Society of Medical Oncology, The National Comprehensive Cancer Netwo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855334/ https://www.ncbi.nlm.nih.gov/pubmed/27148438 http://dx.doi.org/10.1186/s13569-016-0047-1 |
_version_ | 1782430348731219968 |
---|---|
author | Gerrand, Craig Athanasou, Nick Brennan, Bernadette Grimer, Robert Judson, Ian Morland, Bruce Peake, David Seddon, Beatrice Whelan, Jeremy |
author_facet | Gerrand, Craig Athanasou, Nick Brennan, Bernadette Grimer, Robert Judson, Ian Morland, Bruce Peake, David Seddon, Beatrice Whelan, Jeremy |
author_sort | Gerrand, Craig |
collection | PubMed |
description | This document is an update of the British Sarcoma Group guidelines published in 2010. The aim is to provide a reference standard for the clinical care of patients in the UK with bone sarcomas. Recent recommendations by the European Society of Medical Oncology, The National Comprehensive Cancer Network and The National Institute for Health and Care Excellence have been incorporated, and the literature since 2010 reviewed. The standards represent a consensus amongst British Sarcoma Group members in 2015. It is acknowledged that these guidelines will need further updates as care evolves. The key recommendations are that bone pain or a palpable mass should always lead to further investigation and that patients with clinico-radiological findings suggestive of a primary bone tumour at any site in the skeleton should be referred to a specialist centre and managed by a fully accredited bone sarcoma multidisciplinary team. Treatment recommendations are provided for the major tumour types and for localised, metastatic and recurrent disease. Follow up schedules are suggested. |
format | Online Article Text |
id | pubmed-4855334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48553342016-05-05 UK guidelines for the management of bone sarcomas Gerrand, Craig Athanasou, Nick Brennan, Bernadette Grimer, Robert Judson, Ian Morland, Bruce Peake, David Seddon, Beatrice Whelan, Jeremy Clin Sarcoma Res Review This document is an update of the British Sarcoma Group guidelines published in 2010. The aim is to provide a reference standard for the clinical care of patients in the UK with bone sarcomas. Recent recommendations by the European Society of Medical Oncology, The National Comprehensive Cancer Network and The National Institute for Health and Care Excellence have been incorporated, and the literature since 2010 reviewed. The standards represent a consensus amongst British Sarcoma Group members in 2015. It is acknowledged that these guidelines will need further updates as care evolves. The key recommendations are that bone pain or a palpable mass should always lead to further investigation and that patients with clinico-radiological findings suggestive of a primary bone tumour at any site in the skeleton should be referred to a specialist centre and managed by a fully accredited bone sarcoma multidisciplinary team. Treatment recommendations are provided for the major tumour types and for localised, metastatic and recurrent disease. Follow up schedules are suggested. BioMed Central 2016-05-04 /pmc/articles/PMC4855334/ /pubmed/27148438 http://dx.doi.org/10.1186/s13569-016-0047-1 Text en © Gerrand et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Gerrand, Craig Athanasou, Nick Brennan, Bernadette Grimer, Robert Judson, Ian Morland, Bruce Peake, David Seddon, Beatrice Whelan, Jeremy UK guidelines for the management of bone sarcomas |
title | UK guidelines for the management of bone sarcomas |
title_full | UK guidelines for the management of bone sarcomas |
title_fullStr | UK guidelines for the management of bone sarcomas |
title_full_unstemmed | UK guidelines for the management of bone sarcomas |
title_short | UK guidelines for the management of bone sarcomas |
title_sort | uk guidelines for the management of bone sarcomas |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855334/ https://www.ncbi.nlm.nih.gov/pubmed/27148438 http://dx.doi.org/10.1186/s13569-016-0047-1 |
work_keys_str_mv | AT gerrandcraig ukguidelinesforthemanagementofbonesarcomas AT athanasounick ukguidelinesforthemanagementofbonesarcomas AT brennanbernadette ukguidelinesforthemanagementofbonesarcomas AT grimerrobert ukguidelinesforthemanagementofbonesarcomas AT judsonian ukguidelinesforthemanagementofbonesarcomas AT morlandbruce ukguidelinesforthemanagementofbonesarcomas AT peakedavid ukguidelinesforthemanagementofbonesarcomas AT seddonbeatrice ukguidelinesforthemanagementofbonesarcomas AT whelanjeremy ukguidelinesforthemanagementofbonesarcomas AT ukguidelinesforthemanagementofbonesarcomas |